- Open Access
Wanted: unique names for unique atom positions. PDB-wide analysis of diastereotopic atom names of small molecules containing diphosphate
© Bottoms and Xu; licensee BioMed Central Ltd. 2008
- Published: 12 August 2008
Biological chemistry is very stereospecific. Nonetheless, the diastereotopic oxygen atoms of diphosphate-containing molecules in the Protein Data Bank (PDB) are often given names that do not uniquely distinguish them from each other due to the lack of standardization. This issue has largely not been addressed by the protein structure community.
Of 472 diastereotopic atom pairs studied from the PDB, 118 were found to have names that are not uniquely assigned. Among the molecules identified with these inconsistencies were many cofactors of enzymatic processes such as mononucleotides (e.g. ADP, ATP, GTP), dinucleotide cofactors (e.g. FAD, NAD), and coenzyme A. There were no overall trends in naming conventions, though ligand-specific trends were prominent.
The lack of standardized naming conventions for diastereotopic atoms of small molecules has left the ad hoc names assigned to many of these atoms non-unique, which may create problems in data-mining of the PDB. We suggest a naming convention to resolve this issue. The in-house software used in this study is available upon request.
A version of the software used for the analyses described in this paper is available at our web site: http://digbio.missouri.edu/ddan/DDAN.htm.
- Protein Data Bank
- Root Mean Square Deviation
- Phosphorus Atom
- Naming Convention
Often accompanying the macromolecules deposited in the Protein Data Bank (PDB)  are smaller molecules of biological importance. Some of these are energy-carrying cofactors, such as ATP, coenzyme A, and nicotinamide-adenine dinucleotide (NAD). Some analogs of these molecules are either drugs or can be used in drug design [2, 3].
The pro-S and pro-R oxygen atoms of nucleic acid strands are named "OP1" and "OP2", respectively . Many enzymes treat the pro-R and pro-S oxygen atoms of DNA and RNA differently . These diastereotopic oxygen atoms are also treated differently in RNA-intron splicing [6, 7]. Small diphosphate-containing molecules also participate in enzymatic reactions in which the distinction between diastereotopic atoms or groups is important [5, 8, 9]. Unfortunately, many of these diastereotopic atoms do not have standardized names, an issue that has not been investigated to our knowledge. Consistent naming of diastereotopic atoms is needful when performing all-atom superpositioning or all-atom root mean square deviation (RMSD) calculation . It is also needful for data mining in the PDB, e.g., structure-based virtual screening for drug candidates [11, 12]. In this paper, we will conduct a systematic PDB-wide analysis on the diastereotopic atom names of small molecules containing diphosphate.
Inconsistencies in PDB files
There were 4167 PDB files containing a total of 295 distinct ligands having prochiral centers that met our strict criteria. Over half of these ligands (175) had two prochiral phosphate centers that were adjacent to carbon, and one had three (OXT from [PDB:2JI7] ), for a total of 472 distinct prochiral centers adjacent to carbon. For example, NAD contains two because it has a diphosphate sandwiched between two ribose moieties. Each distinct prochiral center contains a pair of disastereotopic atoms. We analyzed the names of the atoms at each prochiral center. Of these distinct centers, 354 had a single naming convention but 241 of these also only occurred in a single PDB file. There were 118 distinct prochirality centers that had more than one naming convention.
We defined a case of swapped names to occur when all of the following were true between two molecules with the same type of prochiral center: (1) the highest and second highest priority names were consistent, (2) the pro-R atom of one prochiral center had the same name as the pro-S atom of a second center, and (3) the pro-S atom of the first center had the same name as the pro-R atom of the second center (Figure 2). 117 of the 118 centers had swapped naming conventions as defined above. The remaining center, which had two naming conventions, actually had a naming error. Nine of the 117 centers with swapped names had additional naming conventions. In every case, we found that the extra naming conventions were caused by errors rather than mere inconsistencies. For example, in a structure of a surfactin synthetase-activating enzyme [PDB:1QR0] , the diastereotopic atoms attached to phosphorus atom P1A are labeled "O5A" and "O4A" instead of the names "O2A" and "O1A" defined in the Chemical Component Dictionary http://deposit.rcsb.org/het_dictionary.txt from the PDB. In a similar manner, the diastereotopic atoms attached to P2A are named "O2A" and "O1A", instead of the names "O5A" and "O4A" defined in the dictionary file. In another example, in a structure of E. coli carbamoyl phosphate synthetase [PDB:1CE8]  the O5' oxygen atom is mislabeled as O4' for 8 different ADP molecules. Interestingly, in four of these molecules, the pro-S and pro-R atoms are labeled "O1A" and "O2A", respectively, while in the other four molecules they are labeled "O2A" and "O1A", respectively.
Naming convention statistics for selected ligands
nadp nicotinamide-adenine-dinucleotide phosphate
thiamine diphosphate (i.e. vitamin B1)
Examples of naming inconsistencies
Most of the atom naming inconsistencies mentioned in this paper relate to differences found between different files. However, there are a few cases in which naming inconsistencies can be found within a single file. One example is an X-ray crystal structure of alcohol dehydrogenase [PDB:2OHX] . This structure contains two NAD molecules (see Figure 2). The prochiral center around phosphorus atom PN has consistent naming between the two molecules, however the prochiral center around phosphorus atom PA does not. In one case the pro-S and pro-R atoms are named "O1A" and "O2A", respectively, and in the other case, the names are "O2A" and "O1A", respectively.
The inconsistent naming of atoms discussed in our paper is due largely to a lack of standardized names, not due to errors on the part of crystallographers or NMR researchers. There can be no errors where there are no rules.
A study of NAD(P) molecules by Carugo and Argos ignored the diastereotopic oxygen atoms for purposes of superimposing molecules because of naming inconsistencies . Despite their use of atom-specific names for other atoms in the molecules, they only generally referred to diastereotopic oxygen atoms as "terminal oxygen atoms". That was eleven years ago and only involved a study of 32 protein structures. This was long before the recent remediation project of the PDB . This project has done well to bring molecular and atomic naming conventions for PDB files into conformity with standards established by the International Union of Pure and Applied Chemistry (IUPAC) and the International Union of Biochemistry and Molecular Biology (IUBMB). However, IUPAC and IUBMB do not have standards for most diastereotopic atoms of small molecules.
There were no obvious overall trends in naming conventions with respect to the pro-R and pro-S atoms. This is likely due to the lack of naming standardization. However, trends are commonly seen among specific ligands (Table 1). One interesting observation is that the P prochiral center of FAD is highly biased in its naming convention (87% for one convention); however, the second center, PA has little bias (54% for one convention). Another observation is that NAD-like ligands tend to have naming conventions such that similar names (e.g. O1A and O1N) are seen on the same "side" of the molecule.
We suggest a general rule that names for pro-S atoms come alphanumerically before names for pro-R atoms. This is similar to the standard of using "OP1" for pro-S and "OP2" for pro-R in nucleic acids. The data indicates that there is no strong bias for this nor for its opposite convention among diphosphate containing ligands.
Regardless of what rules may become adopted, it is important to know to which atom a particular name refers. Establishing standard names and topologies that take prochirality into consideration will result in less confusion and more accuracy in studies involving small molecules. Until standards are adopted, individuals mining the data need to do their own standardization of the names. This naming can be enforced upfront, prior to the official release of data, or it can be enforced by individuals mining the data.
Current naming conventions do not completely map unique names to unique diastereotopic atoms, resulting in possible confusion or error, or at least the need for researchers to impose their own naming standardization. We herein describe many cases of naming inconsistencies for small molecules containing diphosphate moieties. A future study will assess naming conventions of all atoms in the PDB, addressing more general issues of chirality and prochirality. The in-house software used in this study is available upon request.
Selection of small molecules for analysis
PDB files were selected from the January 7, 2008 "snapshot" of the Protein Data Bank. The search feature of the Protein Data Bank website http://www.pdb.org/pdb/search/advSearch.do was used to select PDB codes for files containing ligands that had substructures matching the SMILES pattern "C~O~P(~O)(~O)~O~P(~O)(~O)~O". Here, "C" represents a carbon atom, "~" represents any bond, "O" represents oxygen, "P" represents phosphorus, and the parentheses indicate that the oxygen atoms inside them are bonded to the preceding phosphorus atom in the list, not to subsequent atoms in the list. This matches any ligand containing a (PO4)2 moiety, such as NAD, ATP, and Coenzyme A, resulting in a list of 4435 PDB codes.
Since the PDB files corresponding to these codes also included other ligands not meeting our criteria, we analyzed each of the small molecules within each PDB file and selected each one that met the following criteria: (1) It did not have the same residue name as an amino acid or nucleic acid, including names mapped to standard residue names via the "MODRES" record. (2) It had an entry in the Chemical Component Dictionary http://deposit.rcsb.org/het_dictionary.txt from the PDB. (3) It had complete coordinates for the non-hydrogen atoms specified in the Chemical Component Dictionary. And (4), it had a diphosphate group attached to carbon, with the diphosphate group consisting of two phosphorus atoms, each covalently bonded to four oxygen atoms. We chose to analyze the prochiral phosphate centers adjacent to carbon atoms because of their abundance and because it allowed a simple and direct application of the CIP algorithm.
Atoms were considered to be covalently bonded if the distance between their centers was less than the sum of their covalent radii plus a cushion of 0.4 Å, following the custom of the Cambridge Structural Database (CSD) . Covalent radii were obtained from the CSD website http://www.ccdc.cam.ac.uk/products/csd/radii/.
Also excluded were molecules that had alternate conformations that shared the same residue number. This guaranteed that any modeled alternate conformations would contain complete molecules. Those files containing diphosphates were further checked for phosphorus atoms having a prochiral configuration (see Determination of Prochiral Centers below). For those that did, the names of all four atoms attached to the prochiral center were recorded along with their relative stereochemical positions. Of the 4435 files originally selected, 4184 were found to have at least one ligand with a prochiral phosphate atom.
Determination of prochiral centers
The CIP algorithm [20, 21] for assigning priorities to atoms within a molecule was implemented using in-house software. CIP priorities were calculated for all four atoms connected to a phosphorus atom. Following the CIP-algorithm, the oxygen atom attached to two phosphorus atoms always had the highest priority and the oxygen atom attached to carbon always had the second highest priority. The two remaining oxygen atoms were not bonded to any other atom besides the phosphorus atom.
XN, YN, and ZN are the x, y, and z components of the coordinates for group N. The subscripted letters A, B, C, and D represent the highest, second highest, third highest, and lowest priority atoms, respectively (see Figure 1). m is the result of calculating the determinant. It is negative for the R configuration and positive for the S configuration. If it is evaluated to be zero, then the atoms are all in the same plane , which should never be the case for tetrahedrally arranged molecules such as phosphates. For understanding the mathematics behind this equation and how it captures the handedness of four three-dimensional coordinates, we refer the reader to the work of Cieplak and Wisniewski .
If m is positive, then C is the pro-S atom and, concomitantly, C' is the pro-R atom (Figure 2). If m is negative, then C is the pro-R atom and C' is the pro-S atom.
Third-party software used
COOT  was used for visualizing PDB files, which was especially useful during the development of our software. As needed, the SSM  module of COOT was also used for superposition of molecules. Pymol was used for viewing NMR models as well as generating depictions of molecular structures for figures .
CAB was supported by NIH Grant Number 2-T15-LM07089-16 from the National Library of Medicine. DX was supported by an NIH Grant (1R21GM078601-01).
This article has been published as part of BMC Bioinformatics Volume 9 Supplement 9, 2008: Proceedings of the Fifth Annual MCBIOS Conference. Systems Biology: Bridging the Omics. The full contents of the supplement are available online at http://www.biomedcentral.com/1471-2105/9?issue=S9
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res 2000,28(1):235–242. [http://www.rcsb.org/] 10.1093/nar/28.1.235PubMed CentralView ArticlePubMedGoogle Scholar
- Faig M, Bianchet MA, Winski S, Hargreaves R, Moody CJ, Hudnott AR, Ross D, Amzel LM: Structure-based development of anticancer drugs: complexes of NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones. Structure 2001,9(8):659–667. 10.1016/S0969-2126(01)00636-0View ArticlePubMedGoogle Scholar
- Bressi JC, Verlinde CL, Aronov AM, Shaw ML, Shin SS, Nguyen LN, Suresh S, Buckner FS, Van Voorhis WC, Kuntz ID, Hol WG, Gelb MH: Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design. J Med Chem 2001,44(13):2080–2093. 10.1021/jm000472oPubMed CentralView ArticlePubMedGoogle Scholar
- Newsletter 1984 European Journal of Biochemistry 1984,138(1):5–7. 10.1111/j.1432-1033.1984.tb07876.xGoogle Scholar
- Eckstein F: Nucleoside phosphorothioates. Annu Rev Biochem 1985, 54: 367–402. 10.1146/annurev.bi.54.070185.002055View ArticlePubMedGoogle Scholar
- Cech TR, Herschlag D, Piccirilli JA, Pyle AM: RNA catalysis by a group I ribozyme. Developing a model for transition state stabilization. J Biol Chem 1992,267(25):17479–17482.PubMedGoogle Scholar
- Padgett RA, Podar M, Boulanger SC, Perlman PS: The stereochemical course of group II intron self-splicing. Science 1994,266(5191):1685–1688. 10.1126/science.7527587View ArticlePubMedGoogle Scholar
- Domanico PL, Rahil JF, Benkovic SJ: Unambiguous stereochemical course of rabbit liver fructose bisphosphatase hydrolysis. Biochemistry 1985,24(7):1623–1628. 10.1021/bi00328a009View ArticlePubMedGoogle Scholar
- Tsai MD: Use of phosphorus-31 nuclear magnetic resonance to distinguish bridge and nonbridge oxygens of oxygen-17-enriched nucleoside triphosphates. Stereochemistry of acetate activation by acetyl coenzyme A synthetase. Biochemistry 1979,18(8):1468–1472. 10.1021/bi00575a013View ArticlePubMedGoogle Scholar
- Schultze P, Feigon J: Chirality errors in nucleic acid structures. Nature 1997,387(6634):668. 10.1038/42632View ArticlePubMedGoogle Scholar
- Waszkowycz B: Towards improving compound selection in structure-based virtual screening. Drug Discov Today 2008,13(5–6):219–226. 10.1016/j.drudis.2007.12.002View ArticlePubMedGoogle Scholar
- Good A: Structure-based virtual screening protocols. Curr Opin Drug Discov Devel 2001,4(3):301–307.PubMedGoogle Scholar
- Berthold CL, Toyota CG, Moussatche P, Wood MD, Leeper F, Richards NG, Lindqvist Y: Crystallographic snapshots of oxalyl-CoA decarboxylase give insights into catalysis by nonoxidative ThDP-dependent decarboxylases. Structure 2007,15(7):853–861. 10.1016/j.str.2007.06.001View ArticlePubMedGoogle Scholar
- Reuter K, Mofid MR, Marahiel MA, Ficner R: Crystal structure of the surfactin synthetase-activating enzyme sfp: a prototype of the 4'-phosphopantetheinyl transferase superfamily. The EMBO journal 1999,18(23):6823–6831. 10.1093/emboj/18.23.6823PubMed CentralView ArticlePubMedGoogle Scholar
- Thoden JB, Raushel FM, Wesenberg G, Holden HM: The binding of inosine monophosphate to Escherichia coli carbamoyl phosphate synthetase. J Biol Chem 1999,274(32):22502–22507. 10.1074/jbc.274.32.22502View ArticlePubMedGoogle Scholar
- Al-Karadaghi S, Cedergren-Zeppezauer ES, Hovmoller S: Refined crystal structure of liver alcohol dehydrogenase-NADH complex at 1.8 Å resolution. Acta Crystallogr D Biol Crystallogr 1994, 50: 793–807. 10.1107/S0907444994005263View ArticlePubMedGoogle Scholar
- Carugo O, Argos P: NADP-dependent enzymes. I: Conserved stereochemistry of cofactor binding. Proteins 1997,28(1):10–28. 10.1002/(SICI)1097-0134(199705)28:1<10::AID-PROT2>3.0.CO;2-NView ArticlePubMedGoogle Scholar
- Henrick K, Feng Z, Bluhm WF, Dimitropoulos D, Doreleijers JF, Dutta S, Flippen-Anderson JL, Ionides J, Kamada C, Krissinel E, Lawson CL, Markley JL, Nakamura H, Newman R, Shimizu Y, Swaminathan J, Velankar S, Ory J, Ulrich EL, Vranken W, Westbrook J, Yamashita R, Yang H, Young J, Yousufuddin M, Berman HM: Remediation of the protein data bank archive. Nucleic Acids Res 2008, (36 Database):D426–433.Google Scholar
- Allen FH: The Cambridge Structural Database: a quarter of a million crystal structures and rising. Acta Crystallogr B 2002, 58: 380–388. 10.1107/S0108768102003890View ArticlePubMedGoogle Scholar
- Cahn RS, Ingold C, Prelog V: Specification of molecular chirality. Angew Chem Int Ed Engl 1966,5(4):385–415. 10.1002/anie.196603851View ArticleGoogle Scholar
- Prelog V, Helmchen G: Basic principles of the CIP-system and proposals for a revision. Angew Chem Int Ed Engl 1982,21(8):567–583. 10.1002/anie.198205671View ArticleGoogle Scholar
- Cieplak T, Wisniewski J: A new effective algorithm for the unambiguous identification of the stereochemical characteristics of compounds during their registration in databases. Molecules 2001, 6: 915–926.View ArticleGoogle Scholar
- Emsley P, Cowtan K: Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 2004,60(Pt 12 Pt 1):2126–2132. 10.1107/S0907444904019158View ArticlePubMedGoogle Scholar
- Krissinel E, Henrick K: Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr D Biol Crystallogr 2004,60(Pt 12 Pt 1):2256–2268. 10.1107/S0907444904026460View ArticlePubMedGoogle Scholar
- DeLano WL: The PyMOL molecular graphics system.San Carlos, CA, USA: DeLano Scientific; 2002. [http://pymol.sourceforge.net]Google Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.